Evaluation of California's Armed & Prohibited Persons System

Status Active, not recruiting

Clinical Trial Summary

This study evaluates exposure to California's Armed and Prohibited Persons System (APPS) and risk of future violence and other important outcome events among individuals who legally purchased firearms in the past but have since become prohibited from owning them. The main hypothesis is that APPS will be associated with a significant reduction in risk for future violence among individuals who are directly affected.

Clinical Trial Description

Violence remains an important public safety and public health problem. Prior research has shown that denying firearm purchases by individuals who are at high risk for committing violent crimes, thereby restricting their access to firearms, is an effective violence prevention strategy. The Armed and Prohibited Persons System (APPS) is a new violence prevention initiative undertaken by the California Department of Justice (CalDOJ). APPS is used by law enforcement to systematically identify persons who, having legally purchased firearms in the past, have become prohibited persons in the present-usually as the result of a criminal conviction. Such individuals are at increased risk for future violence. APPS uses existing data to identify firearm owners among persons who have become prohibited from owning or possessing firearms under California or federal law. CalDOJ then uses this information to contact and attempt recovery of firearms in the possession of prohibited individuals. This controlled prospective longitudinal evaluation of APPS relies principally on data collected by CalDOJ in the course of APPS operations or on data in the public domain, such as community characteristics published by the U.S. Census Bureau. To maximize fairness during the implementation of APPS, approximately 1,000 California communities will be stratified by region, population, and violent crime rate and randomized into two groups that will be exposed to APPS at different times during the study period. Hierarchical analysis will examine outcomes for individuals clustered at the community level. The principal analysis will be on an intent to treat basis. A secondary per protocol analysis will also be conducted. ;

Study Design

Related Conditions & MeSH terms

Violence

Clinical Trial Details

NCT number	NCT02318732
Study type	Interventional
Source	University of California, Davis
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 2015
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00729391` - Women-Focused HIV Prevention in the Western Cape	Phase 2/Phase 3
Recruiting	`NCT06062732` - Face It Evaluation	N/A
Withdrawn	`NCT03762356` - Questionnaire About Individual's Insight/Awareness of Risk of Violence
Completed	`NCT02506088` - Preventing Sexual Aggression Among High School Boys	N/A
Completed	`NCT02458365` - A Stage-Based Expert System for Teen Dating Violence Prevention	Phase 2
Completed	`NCT00251212` - Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)	N/A
Completed	`NCT00527358` - Evaluation of SAFER Latinos' Program to Prevent Youth Violence	Phase 2/Phase 3
Completed	`NCT01025674` - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8	N/A
Completed	`NCT00164541` - An Arts-Based Initiative for the Prevention of Violence Against Women and Girls	Phase 1
Recruiting	`NCT05706376` - An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention	N/A
Recruiting	`NCT06001554` - Preventing Physical and Emotional Violence by Teachers in Public Schools in Pakistan	N/A
Recruiting	`NCT05585918` - The R-CITY Project: A Collaborative Intervention With Teachers and Youth	N/A
Recruiting	`NCT06099262` - GenPMTO Evaluation
Recruiting	`NCT05595759` - Violence Against Women in Patients With Alcohol Substance Addiction Training	N/A
Completed	`NCT05207319` - Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia	N/A
Completed	`NCT03473067` - Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools	N/A
Completed	`NCT06056661` - Within My Reach (WMR) Adaptation	N/A
Not yet recruiting	`NCT04520399` - Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning
Not yet recruiting	`NCT02257944` - Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence	N/A
Completed	`NCT01770873` - A Multi-Center Randomized Controlled Trial of Mentoring to Prevent Youth Violence	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of California's Armed and Prohibited Persons System — APPS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms